CSI Market
Sign In | Register

Essa Pharma inc (EPIX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access EPIX quarterly Cash Flow →
The data below summarizes Essa Pharma inc's cash flow activity from Sep 30 2020 to Sep 30 2024, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
12 Months 		(Sep 30 2023) (Sep 30 2022) (Sep 30 2021) (Sep 30 2020)
Operating Activities
Income-28.54
Depreciation & amortization0.00
Amortization of Other Assets0.00
Accretion Expense0.03
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation6.54
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.00
Operating Lease Right Of Use Asset Amortization Expense0.09
Derivative Gain Loss On Derivative Net-
Income Tax Expense Operating Activities-
Amortization Expense Of Tangible And Intangible Assets-
Gains Losses On Change In Fair Value Of Derivatives-
Gain Loss On Asset Acquisition-
Adjustments For Finance Costs-
Revenue From Government Grants-
Adjustments For Decrease Increase In Current Receivables From Tax Credits And Other-
Adjustments For Increase Decrease In Prepaid Expenses-
Adjustments For Increase Decrease In Account Payable And Accrued Liabilities-
Investment Income Net0.50
Increase Decrease In Operating Lease Liability-0.10
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Receivables0.03
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.24
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.05
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.92
Payments for (Proceeds from) Other Operating Activities-0.92
Discontinued operations0.00
Net Cash flow from Operating Activities-22.72
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds39.23
Short-term Investments Acq.0.00
Real Estate Investments0.00
Interest From Short Term Investments-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Proceeds from Other Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities91.79
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.05
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Cash Acquisition From Acquisition Of Business-
Payment Of Sublease Termination Costs-
Repayments Of Final Payment Of Debt-
Repayments Of Financing Costs-
Increase Decrease In Cash And Cash Equivalents-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.93
Effect of exchange rate on cash flow0.01
Discontinued operations0.00
Free Cash Flow-22.72
Total Cash Flow70.01
4 historic quarters locked

Sign in to unlock the full Essa Pharma inc cash flow history.

Sign In Create Free Account

About Essa Pharma Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-24-016318

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License